From weight-loss drugs to Botox, women are becoming more critical of their appearance in an attempt to keep up with social media trends and influencers ...

Novo Nordisk has announced the filing of 14 new lawsuits against the sale of unapproved compounded drugs claiming to contain semaglutide.

Shares in AMD took a hit and were about 6% lower in pre-market trading after the US chipmaker reported mixed quarterly earnings that missed Wall Street forecasts for adjusted earnings per share, but ...

The number of people taking weight-loss injections is exploding. With more and more men going “on the needle”, here’s what ...

Danish pharmaceutical giant Novo Nordisk posted a sharp rise in second-quarter net profit today, but rising competition is ...

Semaglutide--which is marketed as Wegovy for weight-loss and Ozempic for diabetes--had been in short supply as the company raced to increase production and meet surging demand. But the drug came off ...

Maziar Mike Doustdar will take the helm as CEO tomorrow, with the firm facing tough questions from investors about how it can stay competitive.

Muscle and strength loss in human aging, also known as sarcopenia, can result in trouble with balance and walking, according ...

Weston's downgrade still values Novo Nordisk stock above its current share price of $47 and change, however. Moreover, Novo ...

Novo Nordisk is scheduled to report results for the second quarter on Wednesday. Here is what you need to know: PROFIT FORECAST: The company pre-released preliminary second-quarter numbers last week, ...